State Key Laboratory of Medicinal Chemical Biology and Drug Discovery Center for Infectious Disease, College of Pharmacy, Nankai University, Tianjin, China.
MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine and School of Life Sciences, Tsinghua University, Beijing, China.
PLoS Pathog. 2021 Apr 28;17(4):e1009507. doi: 10.1371/journal.ppat.1009507. eCollection 2021 Apr.
The development of a universal vaccine against foot-and-mouth disease virus (FMDV) is hindered by cross-serotype antigenic diversity and by a lack of knowledge regarding neutralization of the virus in natural hosts. In this study, we isolated serotype O-specific neutralizing antibodies (NAbs) (F145 and B77) from recovered natural bovine hosts by using the single B cell antibody isolation technique. We also identified a serotype O/A cross-reacting NAb (R50) and determined virus-NAb complex structures by cryo-electron microscopy at near-atomic resolution. F145 and B77 were shown to engage the capsid of FMDV-O near the icosahedral threefold axis, binding to the BC/HI-loop of VP2. In contrast, R50 engages the capsids of both FMDV-O and FMDV-A between the 2- and 5-fold axes and binds to the BC/EF/GH-loop of VP1 and to the GH-loop of VP3 from two adjacent protomers, revealing a previously unknown antigenic site. The cross-serotype neutralizing epitope recognized by R50 is highly conserved among serotype O/A. These findings help to elucidate FMDV neutralization by natural hosts and provide epitope information for the development of a universal vaccine for cross-serotype protection against FMDV.
口蹄疫病毒(FMDV)的通用疫苗的开发受到跨血清型抗原多样性的阻碍,并且对天然宿主中病毒的中和作用知之甚少。在这项研究中,我们通过使用单 B 细胞抗体分离技术,从恢复的天然牛宿主中分离出了血清型 O 特异性中和抗体(F145 和 B77)。我们还鉴定出了一种血清型 O/A 交叉反应性中和抗体(R50),并通过冷冻电镜在近原子分辨率下确定了病毒-中和抗体复合物的结构。结果表明,F145 和 B77 与 FMDV-O 的衣壳在二十面体三重轴附近结合,与 VP2 的 BC/HI 环结合。相比之下,R50 与 FMDV-O 和 FMDV-A 的衣壳在 2 倍和 5 倍轴之间结合,与 VP1 的 BC/EF/GH 环和来自两个相邻原体的 VP3 的 GH 环结合,揭示了一个以前未知的抗原位点。R50 识别的跨血清型中和表位在血清型 O/A 中高度保守。这些发现有助于阐明天然宿主对 FMDV 的中和作用,并为开发针对 FMDV 的跨血清型保护的通用疫苗提供表位信息。